immunogen safeti intraderm hepat vaccin background chief barrier use hepat vaccin high cost vaccin number small research trial adequ immun respons cost tenth vaccin intraderm techniqu purpos studi result clinic trial method vaccin recipi health care provid polic offic firefight recipi mL plasma-deriv hepat vaccin day antibodi respons day seroconvers sample-to-neg s/n ratio equal local system side effect result six sixteen individu vaccin seri seroconvers rate seroconvers year year mean s/n ratio rang age side effect local reaction conclus result use intraderm techniqu cost-effect altern intramuscular rout individu year intraderm techniqu individu titer seroconvers restrict avail plasma-deriv vaccin studi similar trial recombin vaccin 